Larvol Delta - A-Phase-3-Clinical-Trial-to-Evaluate-the-Safety-and-Efficacy-of-HSK39004-Inhalation-Suspension-in-Patients-With-COPD

AN01 - AirNexis Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07658339

Jun 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next